Color Atlas of Physiology 2003 thieme
.pdfA. Schematic view of autonomic nervous system (ANS)
Parasympathetic division |
|
Controlled |
Sympathetic division |
|
(Thoracic and lumbar centers) |
||
(Craniosacral centers) |
|
by |
|
|
Transmitter substances: |
||
Transmitter substances: |
|
superordinate |
|
|
centers |
Preganglionic: Acetylcholine |
|
Preganglionic: Acetylcholine |
|
||
|
|
Postganglionic: Norepinephrine |
|
Postganglionic: Acetylcholine |
|
|
|
|
|
(Exception: Sweat glands, |
|
|
|
|
some muscular blood vessels) |
|
|
III |
|
|
|
VII |
|
|
|
IX |
|
Eye |
|
X |
α |
|
|
||
|
|
|
β Eye |
|
|
Vagus |
α |
|
|
Glands |
|
Glands |
nerve |
|
|
|
|
|
β |
Heart |
|
Heart |
|
|
Bronchi
Thoracic
Gastrointestinal tract
Lumbar
Ureter
Lower colon
Sacral
Urinary
bladder Genitals
Cholinoceptors
Nicotinic receptors:
–All postganglionic, autonomic ganglia cells and dendrites
–Adrenal medulla
Muscarinic receptors:
–All target organs innervated by postganglionic parasympathetic nerve fibers
(and sweat glands innervated by sympathetic fibers)
|
|
α |
|
|
|
|
|
|
|
|
|
|
|
β |
Blood vessels |
|
|
||
|
|
α |
|
|
|
|
|
|
|
|
|
|
|
β |
Smooth muscle |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
Liver |
|
|
|
|
|
|
|
Pancreas |
|
|
|
|
|
|
|
α + β |
|
|
|
|
|
|
Fat and sugar metabolism |
|
|
|
||
|
|
Cholinergic |
|
|
|
||
|
β |
|
Sweat glands |
α |
|
Genitals |
|
Urinary bladder |
Adrenal medulla |
|
Adrenoceptors:
αUsually excitatory (except in GI tract, where
they are indirect relaxants)
βUsually inhibitory (except in heart, where they are excitatory)
β1 mainly in heart
β2 in bronchi, urinary bladder, uterus, gastrointestinal tract, etc.
Postganglionic: Cholinergic |
Preganglionic: Cholinergic |
Postganglionic: Adrenergic |
Plate 3.1 Organization of ANS
79
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
3 Autonomic Nervous System (ANS)
80
A. Functions of the autonomic nervous system (ANS)
Parasympathetic division (cholinergic) |
Controlled by |
|
||||
|
Ganglia: NN and M1 receptors |
|
||||
|
superordinate centers |
|||||
|
Target organ: M2 oder M3 receptors |
(e.g., hypothalamus) |
||||
|
|
Eye |
|
|
|
|
|
|
Sphincter pupill. |
A |
Ganglion |
|
|
Ganglion sub- |
Ciliary muscle |
C |
|
|
||
ciliare |
|
|
||||
mandibulare |
Lacrimal glands |
A |
Ganglion |
III |
|
|
Submandibular |
|
|
|
VII |
|
|
A |
|
|
pterygopalatinum |
|
||
gland |
|
Chorda tympani |
|
|
|
|
A |
|
|
|
|
||
Parotid gland |
|
|
IX |
|
||
|
|
Ganglion |
Cervical |
|||
|
|
Heart |
|
X |
||
Activation |
|
|
oticum |
|||
|
Slows impulse |
|
1 |
ganglia |
||
|
|
|
||||
|
|
|
|
2 |
|
|
|
|
conduction |
|
|
|
|
Kinin release |
|
|
|
3 |
|
|
|
Heart rate |
|
|
|
||
|
|
|
Cervical |
4 |
|
|
(sometimes with VIP |
Bronchi |
|
|
|||
|
6 |
|
||||
Vasodilatation |
|
|
|
|
5 |
|
|
|
|
|
|
|
|
as co-transmitter) |
|
Secretion |
A |
|
7 |
|
|
|
Musculature |
C |
|
8 |
|
Watery saliva |
|
|
|
|
||
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
Stomach, intestine |
|
2 |
|
|
|
|
|
3 |
|
||
|
|
(w/o lower colon |
|
|
|
|
|
|
and rectum) |
|
|
4 |
|
|
|
Tone |
A |
|
|
|
|
|
|
5 |
|
||
|
|
Sphincter |
R |
Thoracic |
|
|
|
|
Secretion |
A |
6 |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
|
Gallbladder |
C |
|
8 |
|
|
|
|
|
|
9 |
|
Liver |
|
Pancreas |
|
|
10 |
|
|
|
|
11 |
|
||
Glycogenesis |
A |
|
|
|
|
|
Exocrine |
A |
|
12 |
|
||
|
|
|
|
|||
|
|
secretion |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
Lumbar |
2 |
|
Preganglionic |
|
Ureter |
C |
3 |
|
|
|
4 |
|
||||
cholinergic |
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
Lower colon, rectum |
|
|
||
Postganglionic |
|
|
1 |
|
||
|
|
|
|
|
||
cholinergic |
|
Tone |
A |
|
|
|
|
|
2 |
|
|||
|
|
Secretion |
A |
|
|
|
|
|
|
3 |
|
||
|
|
Sphincter |
R |
|
|
|
|
|
|
4 |
|
||
|
|
|
|
Sacral |
|
|
Genitals |
|
Urinary bladder |
5 |
Sympathetic |
||
|
|
|||||
|
|
|
|
|||
Erection |
|
Detrusor |
C |
Spinal cord |
trunk ganglia |
|
(Vasodilatation) |
|
|
||||
|
Sphincter |
R |
|
|||
|
|
|
|
|
||
A = Activation |
I = Inhibition |
C = Contraction |
R = Relaxation |
|
D = Dilatation |
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
Sympathetic division |
(Preganglionic cholinergic: NN and M1 receptors, |
|
|||||||||||||||
|
|
|
|
|
postganglionic mainly adrenergic) |
|
|
||||||||||
α receptors (α1: IP3 +DAG |
|
|
; α2: cAMP |
|
) β receptors (cAMP |
|
) |
|
|
||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eye (α1) |
|
|
|
|
Eye (β2) |
|
Cholinergic |
||||||||
|
C |
Dilator pupillae |
|
|
|
|
Far accommodation |
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
of ciliary muscle |
|
|
|
|||||
|
|
|
|
|
|
|
|
|
S |
A |
Sweat glands |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Submandibular |
|
|
|
Heart (β1 and β2) |
|
|
|
|||||||||
|
|
gland |
|
|
|
|
Faster stimulus |
|
Postganglionic |
||||||||
|
|
|
|
|
|
|
|||||||||||
|
|
Mucus secretion |
|
|
|
conduction |
|
sympathetic |
|||||||||
|
A |
|
|
|
Heart rate |
|
|
|
|
|
|
|
|
||||
|
(viscous) |
|
|
|
|
Myocardial con |
- |
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
traction force |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
Excitability |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S |
C |
Hair muscles |
|
|
|
|
D |
Bronchi (β2) |
|||
of skin |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Stomach, intestine |
|
Stomach, intestine |
||
Ganglion |
C |
Sphincter (α1) |
|
R |
Muscle |
coeliacum |
|
|
|
|
|
R |
Gallbladder |
|
|
|
Kidney |
|
Pancreas |
A |
Renin |
|
|
secretion (β1) |
|
I |
Insulin |
|
Pancreas |
|
secretion (α2) |
|
|
|
|
I |
Exocrine |
|
|
A |
Insulin |
|
|
|
secretion |
|
|
secretion (β2) |
||
Ganglion |
|
|
|
|
|
|
|
|
mesentericum |
|
|
|
|
|
|
Blood vessels |
|
|
C |
Splenic capsule |
|
|
|
|||
sup. et inf. |
|
S |
|
D |
Skin, muscles, |
|||
|
|
S |
|
|
|
etc. |
||
|
|
|
|
|
|
|
|
|
|
|
|
Blood vessels |
|
|
|
Lipocytes |
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
||
|
|
|
C |
In skin |
S |
|
Lipolysis |
|
|
|
|
|
In muscles |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coronaries |
|
|
|
|
|
|
|
|
General |
|
|
|
|
|
|
|
|
|
|
|
Liver (β2 and α1) |
|
|
|
|
|
Genitals (α1) |
|
|
Gluconeogenesis |
|
|
|
|
|
Ejaculation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urinary bladder |
|
|
Urinary bladder |
|
|
|
|
C |
Sphincter |
|
|
R |
Detrusor (β2) |
|
|
|
|
|
|
|
|
|
|
|
|
C |
Uterus (α1) |
|
|
R |
Uterus (β2) |
|
|
|
|
(in pregnancy) |
|
|
|
(Tocolysis) |
S = Efferents from affiliated CNS segment
Blood vessels
S D
Sympathetic cholinergic vasodilatation (not confirmed in humans)
Adrenal medulla
A Secretion
Preganglionic cholinergic
Postganglionic adrenergic
Plate 3.2 u. 3.3 Functions of ANS
81
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
3 Autonomic Nervous System (ANS)
82
Acetylcholine and Cholinergic
Transmission
Acetylcholine (ACh) serves as a neurotransmitter not only at motor end plates (!p. 56) and in the central nervous system, but also in the autonomic nervous system, ANS (!p. 78ff.), where it is active
in all preganglionic fibers of the ANS;
in all parasympathetic postganglionic nerve endings;
and in some sympathetic postganglionic nerve endings (sweat glands).
Acetylcholine synthesis. ACh is synthesized in the cytoplasm of nerve terminals, and acetyl coenzyme A (acetyl-CoA) is synthesized in mitochondria. The reaction acetyl-CoA + choline is catalyzed by choline acetyltransferase, which is synthesized in the soma and reaches the nerve terminals by axoplasmic transport (!p. 42). Since choline must be taken up from extracellular fluid by way of a carrier, this is the ratelimiting step of ACh synthesis.
Acetylcholine release. Vesicles on presynaptic nerve terminals empty their contents into the synaptic cleft when the cytosolic Ca2+ concentration rises in response to incoming action potentials (AP) (!A, p. 50ff.). Epinephrine and norepinephrine can inhibit ACh release by stimulating presynaptic α2-adrenoceptors (!p. 84). In postganglionic parasympathetic fibers, ACh blocks its own release by binding to presynaptic autoreceptors (M-receptors; see below), as shown in B.
ACh binds to postsynaptic cholinergic receptors or cholinoceptors in autonomic ganglia and organs innervated by parasympathetic fibers, as in the heart, smooth muscles (e.g., of the eye, bronchi, ureter, bladder, genitals, blood vessels, esophagus, and gastrointestinal tract), salivary glands, lacrimal glands, and (sympathetically innervated) sweat glands (!p. 80ff.). Cholinoceptors are nicotinic (N) or muscarinic (M). N-cholinocep- tors (nicotinic) can be stimulated by the alkaloid nicotine, whereas M-cholinoceptors (muscarinic) can be stimulated by the alkaloid mushroom poison muscarine.
Nerve-specific NN-cholinoceptors on autonomic ganglia (!A) differ from musclespecific NM-cholinoceptors on motor end plates (!p. 56) in that they are formed by
different subunits. They are similar in that they are both ionotropic receptors, i.e., they act as cholinoceptors and cation channels at the same time. ACh binding leads to rapid Na+ and Ca2+ influx and in early (rapid) excitatory postsynaptic potentials (EPSP; !p. 50ff.), which trigger postsynaptic action potentials (AP) once they rise above threshold (!A, left panel).
M-cholinoceptors (M1–M5) indirectly affect synaptic transmission through G-proteins (metabotropic receptors).
M1-cholinoceptors occur mainly on autonomic ganglia (!A), CNS, and exocrine gland cells. They activate phospholipase C" (PLC") via Gq protein in the postganglionic neuron. and inositol tris-phosphate (IP3) and diacylglycerol (DAG) are released as second messengers (!p. 276) that stimulate Ca2+ influx and a late EPSP (!A, middle panel). Synaptic signal transmission is modulated by the late EPSP as well as by co-transmitting peptides that trigger peptidergic EPSP or IPSP (!A, right panel).
M2-cholinoceptors occur in the heart and function mainly via a Gi protein (!p. 274 ff.). The Gi protein opens specific K+ channels located mainly in the sinoatrial node, atrioventricular (AV) node, and atrial cells, thereby exerting negative chronotropic and dromotropic effects on the heart (!B). The Gi protein also inhibits adenylate cyclase, thereby reducing Ca2+ influx (!B).
M3-cholinoceptors occur mainly in smooth muscles. Similar to M1-cholinoceptors (!A, middle panel), M3-cholinoceptors trigger contractions by stimulating Ca2+ influx (!p. 70). However, they can also induce relaxation by activating Ca2+-dependent NO synthase, e.g., in endothelial cells (!p. 278).
Termination of ACh action is achieved by acetylcholinesterase-mediated cleavage of ACh molecules in the synaptic cleft (!p. 56). Approximately 50% of the liberated choline is reabsorbed by presynaptic nerve endings (!B).
Antagonists. Atropine blocks all M-cholino- ceptors, whereas pirenzepine selectively blocks M1-cholinoceptors, tubocurarine blocks NM-cholinoceptors (!p. 56), and trimetaphan blocks NN-cholinoceptors.
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
A. Neurotransmission in autonomic ganglia |
|
|
|
Transmission |
|||
|
|
|
|
Preganglionic |
|
|
|
Presynaptic AP |
|
ACh |
neuron |
|
|
||
|
|
|
|
|
|||
|
Ca2+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cholinergic |
|
|
|
|
Peptide as a |
Cholinergic |
|
NN-receptor |
|
|
|
|
|||
|
|
Cholinergic |
Peptide |
co-transmitter |
|||
|
|
|
|
||||
|
|
M1-receptor |
receptor |
|
|
||
K+ |
|
Gq protein |
PIP |
|
Postganglionic |
and |
|
|
Phospholipase Cβ |
|
|||||
|
|
|
|
neuron |
Acetylcholine |
||
Na+ (Ca2+) |
IP3 |
DAG |
[Ca]i |
|
|
|
|
|
|
|
|
||||
20ms Early EPSP |
|
2s |
Late EPSP |
Peptidergic EPSP or IPSP |
60s |
||
|
|
||||||
mV |
mV |
|
|
mV |
|
|
Plate 3.4 |
|
Postsynaptic action potentials |
|
|
|
|
B. Cholinergic transmission in the heart |
|
|
|
||
Presynaptic AP |
|
ACh |
Postganglionic |
|
|
|
|
|
parasympathetic |
|
|
|
Ca2+ |
|
neuron |
|
|
|
|
|
|
|
|
Cholinergic |
|
|
|
Choline |
|
|
|
|
|
|
|
M-autoreceptor |
|
|
|
|
Acetate |
|
|
|
|
Acetylcholine |
|
|
|
|
|
|
|
|
Cholinergic |
|
|
esterase |
|
|
|
K+ channel |
|
|
|
|
M2-receptor |
|
|
|
|
Adenylyl cyclase |
Gi protein |
Gi protein |
|
|
|
|
|
|
opens |
Sinus node |
|
ATP |
|
|
|
|
|
|
|
|
K+ |
or AV node cell |
|
cAMP |
|
|
Hyperpolarization |
|
|
|
|
|
|
||
Protein kinase A |
Sinus node |
|
AV node |
|
|
|
|
|
|
|
|
|
0 |
|
|
0 |
|
Ca2+ influx |
mV |
|
|
mV |
|
|
|
|
|
||
|
–50 |
|
|
–50 |
|
|
|
|
|
|
83 |
|
Negative chronotropism |
Negative dromotropism |
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
|
|
Catecholamine, Adrenergic |
α2, !1 and !2) can be distinguished according |
|||
|
|
to their affinity to E and NE and to numerous |
||||
|
|
Transmission and Adrenoceptors |
||||
|
|
agonists and antagonists. All adrenoceptors re- |
||||
|
|
|
|
|
||
|
|
Certain neurons can enzymatically produce L- |
spond to E, but NE has little effect on !2- |
|||
|
|
dopa (L-dihydroxyphenylalanine) from the |
adrenoceptors. Isoproterenol |
(isoprenaline) |
||
|
|
amino acid L-tyrosine. L-dopa is the parent |
activates only !-adrenoceptors, and phen- |
|||
|
|
substance of |
dopamine, |
norepinephrine, |
tolamine only blocks α-adrenoceptors. The ac- |
|
(ANS) |
|
and epinephrine—the three natural cate- |
tivities of all adrenoceptors are mediated by G |
|||
|
cholamines, which are enzymatically synthe- |
proteins (!p. 55). |
|
|||
|
sized in this order. Dopamine (DA) is the final |
Different subtypes (α1 A, α1 B, α1 D) of α1- |
||||
System |
|
step of synthesis in neurons containing only |
adrenoceptors can be distinguished (!B1). |
|||
|
the enzyme required for the first step (the aro- |
Their location and function are as follows: CNS |
||||
|
|
|||||
|
|
matic L-amino acid decarboxylase). Dopamine |
(sympathetic activity"), salivary glands, liver |
|||
Nervous |
|
is used as a transmitter by the dopaminergic |
(glycogenolysis"), kidneys (alters threshold |
|||
|
neurons in the CNS and by autonomic neurons |
for renin release; !p. 184), |
and smooth |
|||
|
that innervate the kidney. |
|
muscles (trigger contractions in the arterioles, |
|||
|
Norepinephrine (NE) is produced when a |
uterus, deferent duct, bronchioles, urinary |
||||
Autonomic |
|
second enzyme (dopamine-!-hydroxylase) is |
bladder, gastrointestinal sphincters, and di- |
|||
|
also present. In most sympathetic postgan- |
lator pupillae). |
|
|||
|
|
|
||||
|
|
glionic nerve endings and noradrenergic central |
Activation of α1-adrenoceptors (!B1), me- |
|||
|
|
neurons, NE serves as the neurotransmitter |
diated by Gq proteins and phospholipase C! |
|||
3 |
|
along with the co-transmitters adenosine tri- |
(PLC!), leads to formation of the second mes- |
|||
|
phosphate (ATP), somatostatin (SIH), or neu- |
sengers inositol tris-phosphate (IP3), which in- |
||||
|
|
|||||
|
|
ropeptide Y (NPY). |
|
creases the cytosolic Ca2+ concentration, and |
||
|
|
Within the adrenal medulla (see below) |
diacylglycerol (DAG), which activates protein |
|||
|
|
and adrenergic neurons of the medulla ob- |
kinase C (PKC; see also p. 276). Gq protein-me- |
|||
|
|
longata, phenylethanolamine N-methyltrans- |
diated α1-adrenoceptor activity also activates |
|||
|
|
ferase transforms norepinephrine (NE) into |
Ca2+-dependent K+ channels. The resulting K+ |
|||
|
|
epinephrine (E). |
|
|
outflow hyperpolarizes and relaxes target |
|
|
|
The endings of unmyelinated sympathetic |
smooth muscles, e.g., in the gastrointestinal |
|||
|
|
postganglionic neurons are knobby or varicose |
tract. |
|
||
|
|
(!A). These knobs establish synaptic contact, |
Three subtypes (α2 A, α2 B, α2 C) of α2-adreno- |
|||
|
|
albeit not always very close, with the effector |
ceptors (!B2) can be distinguished. Their lo- |
|||
|
|
organ. They also serve as sites of NE synthesis |
cation and action are as follows: CNS (sympa- |
|||
|
|
and storage. L-tyrosine (!A1) is actively |
thetic activity#, e.g., use of the α2 agonist |
|||
|
|
taken up by the nerve endings and trans- |
clonidine to lower blood pressure), salivary |
|||
|
|
formed into dopamine. In adrenergic stimula- |
glands (salivation#), pancreatic islets (insulin |
|||
|
|
tion, this step is accelerated by protein kinase |
secretion#), lipocytes (lipolysis#), platelets |
|||
|
|
A-mediated (PKA; !A2) phosphorylation of |
(aggregation"), and neurons (presynaptic au- |
|||
|
|
the responsible enzyme. This yields a larger |
toreceptors, see below). Activated α2-adreno- |
|||
|
|
dopamine supply. Dopamine is transferred to |
ceptors (!B2) link with Gi protein and inhibit |
|||
|
|
chromaffin vesicles, where it is transformed |
(via αi subunit of Gi) adenylate cyclase (cAMP |
|||
|
|
into NE (!A3). Norepinephrine, the end prod- |
synthesis#, !p. 274) and, at the same time, in- |
|||
|
|
uct, inhibits further dopamine synthesis |
crease (via the !γ subunit of Gi) the open- |
|||
|
|
(negative feedback). |
|
probability of voltage-gated K+ channels (hy- |
||
|
|
NE release. NE is exocytosed into the synap- |
perpolarization). When coupled with G0 pro- |
|||
|
|
tic cleft after the arrival of action potentials at |
teins, activated α2-adrenoceptors also inhibit |
|||
|
|
the nerve terminal and the initiation of Ca2+ in- |
voltage-gated Ca2+ channels ([Ca2+]i#). |
|||
|
|
flux (!A4 and p. 50). |
|
All "-adrenoceptors are coupled with a GS |
||
84 |
|
Adrenergic |
receptors or |
adrenoceptors |
protein, and its αS subunit releases cAMP as a |
|
|
(!B). Four main types of adrenoceptors (α1, |
second messenger. cAMP then activates pro- |
||||
|
|
!
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
A. Adrenergic transmission |
|
|
|
|
|
|
||
|
|
|
Activates |
|
Adrenal |
|
|
|
|
|
|
Inhibits |
|
medulla |
|
|
|
|
|
|
|
|
|
|
Epinephrine (E) |
|
|
|
Varicosities |
L-tyrosine |
|
|
|
|
I |
|
|
|
|
|
|
Bloodstream |
Transmission |
|
|
|
|
1 |
|
|
|
|
|
|
|
Inactivated |
L-dopa |
2 |
|
β2-adrenoceptor |
||
|
|
|
|
|
|
|||
|
|
|
|
|
|
Adrenergic |
||
|
|
(MAO) |
|
|
|
|
|
|
|
4 |
Dopamine |
cAMP |
|
|
|||
|
|
|
|
|
|
|
||
Action potential |
|
|
|
|
|
|
|
|
|
|
Ca2+ |
|
|
|
|
|
|
|
7 |
|
PKA |
|
|
|
||
|
NE |
NE |
6d |
|
3.5 |
|||
α2-adrenoceptor |
|
|
α2-adreno- |
|||||
|
|
3 |
|
|
|
|||
Heart, glands, |
|
|
|
|
|
|
ceptor |
Plate |
|
|
|
|
|
|
|
||
smooth muscle |
|
6c |
|
|
|
|
|
|
|
5 |
|
|
|
|
|
||
6b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inactivated: |
|
Re- |
|
|
|
|
|
|
|
|
absorption |
|
|
|
|
|
|
by MAO |
|
|
|
|
|
|
|
|
by COMT |
|
|
Norepinephrine |
|
|
|
Epinephrine |
|
|
|
|
(NE) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capillary |
|
|
|
|
|
|
|
|
6a |
|
|
|
|
|
|
|
|
Diffusion into blood |
|
|
|
|
|
|
|
|
(raises NE in blood) |
|
|
|
|
|
|
|
|
|
|
α- |
|
|
|
|
β- |
|
|
|
adrenoceptors |
|
β1 |
adrenoceptors |
β2 |
||
|
α1 |
|
α2 |
|
|
|
||
! |
|
|
|
|
|
|
|
|
tein kinase A (PKA), which phosphorylates different proteins, depending on the target cell type (!p. 274).
NE and E work via "1-adrenoceptors (!B3) to open L-type Ca2+ channels in cardiac cell membranes. This increases the [Ca2+]i and therefore produces positive chronotropic, dromotropic, and inotropic effects. Activated Gs protein can also directly increase the open-
probability of voltage-gated Ca2+ channels in the heart. In the kidney, the basal renin secretion is increased via !1-adrenoceptors.
Activation of "2-adrenoceptors by epineph- |
|
|
rine (!B4) increases cAMP levels, thereby |
|
|
lowering the [Ca2+]i (by a still unclear mecha- |
|
|
nism). This dilates the bronchioles and blood |
|
|
vessels of skeletal muscles and relaxes the |
|
|
! |
85 |
|
muscles of the uterus, deferent duct, and |
||
|
||
! |
|
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
3 Autonomic Nervous System (ANS)
!
gastrointestinal tract. Further effects of !2- adrenoceptor activation are increased insulin secretion and glycogenolysis in liver and muscle and decreased platelet aggregation. Epinephrine also enhances NE release in noradrenergic fibers by way of presynaptic !2- adrenoceptors (!A2, A5).
Heat production is increased via !3-adreno- ceptors on brown lipocytes (!p. 222).
NE in the synaptic cleft is deactivated by
(!A6 a – d):
diffusion of NE from the synaptic cleft into the blood;
extraneuronal NE uptake (in the heart, glands, smooth muscles, glia, and liver), and subsequent intracellular degradation of NE by catecholamine-O-methyltransferase (COMT) and monoamine oxidase (MAO);
active re-uptake of NE (70%) by the presynaptic nerve terminal. Some of the absorbed NE enters intracellular vesicles (!A3) and is reused, and some is inactivated by MAO;
stimulation of presynaptic α2-adrenocep- tors (autoreceptors; !A 6d, 7) by NE in the synaptic cleft, which inhibits the further release of NE.
Presynaptic α2-adrenoceptors can also be found on cholinergic nerve endings, e.g., in the gastrointestinal tract (motility") and cardiac atrium (negative dromotropic effect), whereas presynaptic M-cholinoceptors are present on noradrenergic nerve terminals. Their mutual interaction permits a certain degree of peripheral ANS regulation.
In alarm reactions, secretion of E (and some NE) from the adrenal medulla increases substantially in response to physical and mental or emotional stress. Therefore, cells not sympathetically innervated are also activated in such stress reactions. E also increases neuronal NE release via presynaptic !2-adrenoceptors (!A2). Epinephrine secretion from the adrenal medulla (mediated by increased sympathetic activity) is stimulated by certain triggers, e.g., physical work, cold, heat, anxiety, anger (stress), pain, oxygen deficiency, or a drop in blood pressure. In severe hypoglycemia (!30 mg/dL), for example, the plasma epinephrine concentration can increase by as much as 20-fold, while the norepinephrine concentration increases by a factor of only 2.5, resulting in a corresponding rise in the E/NE ratio.
The main task of epinephrine is to mobilize stored chemical energy, e.g., through lipolysis and glycogenolysis. Epinephrine enhances the uptake of glucose into skeletal muscle (!p. 282) and activates enzymes that accelerate glycolysis and lactate formation (!p. 72ff.). To enhance the blood flow in the muscles involved, the body increases the cardiac output while curbing gastrointestinal blood flow and activity (!p. 75 A). Adrenal epinephrine and neuronal NE begin to stimulate the secretion of hormones responsible for replenishing the depleted energy reserves (e.g., ACTH; !p. 297 A) while the alarm reaction is still in process.
|
Adrenal Medulla |
|
|
After stimulation of preganglionic sympa- |
|
|
thetic nerve fibers (cholinergic transmission; |
|
|
!p. 81), 95% of all cells in the adrenal medulla |
|
|
secrete the endocrine hormone epinephrine |
|
|
(E) into the blood by exocytosis, and another |
|
|
5% release norepinephrine (NE). Compared to |
|
|
noradrenergic neurons (see above), NE synthe- |
|
|
sis in the adrenal medulla is similar, but most |
|
|
of the NE leaves the vesicle and is enzymati- |
|
|
cally metabolized into E in the cytoplasm. |
|
|
Special vesicles called chromaffin bodies then |
|
|
actively store E and get ready to release it and |
|
86 |
co-transmitters (enkephalin, neuropeptide Y) |
|
by exocytosis. |
||
|
Non-cholinergic, Non-adrenergic
Transmitters
In humans, gastrin-releasing peptide (GRP) and vasoactive intestinal peptide (VIP) serve as co-transmitters in preganglionic sympathetic fibers; neuropeptide Y (NPY) and somatostatin (SIH) are the ones involved in postganglionic fibers. Postganglionic parasympathetic fibers utilize the peptides enkephalin, substance P (SP) and/or NPY as co-transmitters.
Modulation of postsynaptic neurons seems to be the primary goal of preganglionic peptide secretion. There is substantial evidence demonstrating that ATP (adenosine triphosphate), NPY and VIP also function as independent neu-
!
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
B. Adrenoceptors |
|
|
|
|
|
|
|
|
|
||
Norepinephrine |
|
Natural agonists |
|
|
Epinephrine |
|
|||||
Agonists: |
Phenylephrine |
|
Clonidine |
|
|
Iso- |
|
Salbu- |
|||
|
|
|
proterenol |
|
tamol |
||||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
II |
|
Antagonists: |
Prazosin |
|
|
Yohimbine |
|
|
Atenolol |
|
Transmission |
||
|
|
|
|
|
|
||||||
receptors:Adrenergic 1 |
α1 |
|
2 |
α2 |
|
3 |
β1 |
4 |
β2 |
||
Gq |
Gq |
Go |
Gi |
Gs |
Gs |
Adrenergic |
|||||
|
|
|
|
||||||||
|
PIP2 |
|
|
|
|
cAMP |
cAMP |
||||
|
|
|
|
cAMP |
|
||||||
K+ |
|
PLCβ |
|
|
|
|
|
|
|||
|
Ca2+ |
|
K+ |
PKA |
PKA |
|
|||||
|
DAG |
|
|
|
|
||||||
|
IP3 |
|
|
|
|
|
|
|
|
3.6 |
|
|
|
|
|
PKA |
|
|
|
|
|
||
PKC |
|
|
|
|
|
|
|
|
Plate |
||
|
|
|
|
|
|
Ca2+ |
? |
|
|||
|
Ca2+ |
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
||
Hyper- |
[Ca2+]i |
|
[Ca2+]i |
|
Hyper- |
[Ca2+]i |
[Ca2+]i |
|
|
||
polarization |
|
|
|
polarization |
|
|
|
|
|
||
Inhibition of |
|
|
|
|
α2 |
|
β1 |
|
|
β2 |
|
gastrointestinal |
|
|
|
|
|
|
|||||
motility |
α1 |
|
Inhibition of |
|
Drives heart |
Dilatation of |
|||||
|
|
α1 |
exocytosis |
|
|||||||
Contraction of |
or secretion |
|
|
|
• Vessels |
|
|||||
|
• Salivary glands |
|
|
• Bronchioles |
|||||||
• Blood vessels |
|
|
|
||||||||
|
|
|
• Uterus |
|
|||||||
• Bronchioles |
|
• Insulin |
|
|
|
|
|||||
|
|
Renin release |
etc. |
|
|
||||||
• Sphincters |
|
• Norepinephrine |
|
|
|||||||
• Uterus |
|
• Acetylcholine |
|
|
|
|
|
||||
etc. |
|
|
etc. |
|
|
|
|
|
|
|
|
! |
|
|
|
|
|
|
|
|
|
|
rotransmitters in the autonomic nervous system. VIP and acetylcholine often occur jointly (but in separate vesicles) in the parasympathetic fibers of blood vessels, exocrine glands, and sweat glands. Within the gastrointestinal tract, VIP (along with nitric oxide) induces the slackening of the circular muscle layer and sphincter muscles and (with the co-transmit- ters dynorphin and galanin) enhances intesti-
nal secretion. Nitric oxide (NO) is liberated from nitrergic neurons (!p. 278)
87
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.
4 |
|
Blood |
|
|
|
|
|
|
||
|
Composition and Function of Blood |
(e.g., heme) can be protected from breakdown |
||||||||
|
and renal excretion. The binding of small |
|||||||||
|
|
|
|
|
|
|||||
|
The blood volume of an adult correlates with |
molecules to plasma proteins reduces their |
||||||||
|
his or her (fat-free) body mass and amounts to |
osmotic efficacy. Many plasma proteins are in- |
||||||||
|
ca. 4–4.5 L in women (!) and 4.5–5 L in men of |
volved in blood clotting and fibrinolysis. |
||||||||
|
70 kg BW ("; !table). The functions of blood |
Serum forms when fibrinogen separates from |
||||||||
|
include the transport of various molecules (O2, |
plasma in the process of blood clotting. |
||||||||
|
CO2, nutrients, metabolites, vitamins, electro- |
The formationofbloodcells occursinthered |
||||||||
|
lytes, etc.), heat (regulation of body tempera- |
bone marrow of flat bone in adults and in the |
||||||||
|
ture) and transmission of signals (hormones) as |
spleen and liver of the fetus. Hematopoietic tis- |
||||||||
|
well as buffering and immune defense. The |
suescontainpluripotent stemcells which,with |
||||||||
|
blood consists of a fluid (plasma) formed el- |
the aid of hematopoietic growth factors (see |
||||||||
|
ements: Red blood cells (RBCs) transport O2 |
below), develop into myeloid, erythroid and |
||||||||
|
and play an important role in pH regulation. |
lymphoid precursor cells. Since pluripotent |
||||||||
|
White blood cells (WBCs) can be divided into |
stem cells are autoreproductive, their existence |
||||||||
|
neutrophilic, |
eosinophilic and basophilic |
is ensured throughout life. In lymphocyte |
|||||||
|
granulocytes, monocytes, and lymphocytes. |
development, lymphocytes arising from lym- |
||||||||
|
Neutrophils play a role in nonspecific immune |
phoid precursor cells first undergo special |
||||||||
|
defense, whereas monocytes and lymphocytes |
differentiation (in the thymus or bone marrow) |
||||||||
|
participate in specific immune responses. |
and are later formed in the spleen and lymph |
||||||||
|
Platelets (thrombocytes) are needed for he- |
nodes as well as in the bone marrow. All other |
||||||||
|
mostasis. Hematocrit (Hct) is the volume ratio |
precursor cells are produced by myelocytopoie- |
||||||||
|
of red cells to whole blood (!C and Table). |
sis, that is, the entire process of proliferation, |
||||||||
|
Plasma is the fluid portion of the blood in |
maturation, and release into the bloodstream |
||||||||
|
which electrolytes, nutrients, metabolites, vi- |
occurs in the bone marrow. Two hormones, er- |
||||||||
|
tamins, hormones, gases, and proteins are dis- |
ythropoietin and thrombopoietin, are involved |
||||||||
|
solved. |
|
|
|
in myelopoiesis. Thrombopoietin |
(formed |
||||
|
|
Plasma proteins (!Table) are involved in |
mainly in the liver) promotes the maturation |
|||||||
|
humoral immune defense and maintain on- |
and development of megakaryocytes from |
||||||||
|
cotic pressure, which helps to keep the blood |
which the platelets are split off. A number of |
||||||||
|
volume constant. By binding to plasma pro- |
othergrowthfactorsaffectbloodcellformation |
||||||||
|
teins, compounds insoluble in water can be |
in bone marrow via paracrine mechanisms. |
||||||||
|
transported in blood, and many substances |
Erythropoietin promotes the maturation and |
||||||||
|
|
|
|
|
|
proliferation of red blood cells. It is secreted by |
||||
|
Blood volume in liters relative to body weight (BW) |
|||||||||
|
the liver in the fetus, and chiefly by the kidney |
|||||||||
|
" 0.041!BW (kg) + 1.53, ! 0.047 !BW (kg) + 0.86 |
(ca. 90%) in postnatal life. In response to an oxy- |
||||||||
|
Hematocrit (cell volume/ blood volume): |
|||||||||
|
gen deficiency (due to high altitudes, hemoly- |
|||||||||
|
" 0.40–0.54 |
Females: 0.37–0.47 |
sis, etc.; !A), erythropoietin secretion in- |
|||||||
|
Erythrocytes (1012/L of blood = 106/ µL of blood): |
|||||||||
|
creases, larger numbers of red blood cells are |
|||||||||
|
" 4.6–5.9 |
! 4.2–5.4 |
produced, and the fraction of reticulocytes |
|||||||
|
Hemoglobin (g/L of blood): |
|||||||||
|
(young erythrocytes) in the blood rises. The life |
|||||||||
|
"140–180 |
! 120–160 |
span of a red blood cell is around 120 days. Red |
|||||||
|
MCH, MCV, MCHC—mean corpuscular (MC), hemo- |
|||||||||
|
blood cells regularly exit from arterioles in the |
|||||||||
|
globin (Hb), MC volume, MC Hb concentration !C |
splenic pulp and travel through small pores to |
||||||||
|
Leukocytes (109/L of blood = 103/ µL of blood): |
|||||||||
|
enter the splenic sinus (!B), where old red |
|||||||||
|
3–11 (64% granulocytes, 31% lymphocytes, |
blood cells are sorted out |
and |
destroyed |
||||||
|
6% monocytes) |
|||||||||
|
(hemolysis). Macrophages in the spleen, liver, |
|||||||||
|
Platelets (109/L of blood = 103/ µL of blood): |
|||||||||
|
bone marrow, etc. engulf and break down the |
|||||||||
|
" 170–360 |
|
!180–400 |
|||||||
88 |
|
cell fragments. Heme, |
the |
iron-containing |
||||||
Plasma proteins (g/L of serum): |
||||||||||
group of hemoglobin |
(Hb) |
released during |
||||||||
|
66–85 (including 55–64% albumin) |
|||||||||
|
hemolysis, is broken |
down into |
bilirubin |
|||||||
|
|
|
|
|
|
(!p. 250), and the iron is recycled (!p. 90).
Despopoulos, Color Atlas of Physiology © 2003 Thieme
All rights reserved. Usage subject to terms and conditions of license.